Abstract
The U.S. cold, flu, and allergy remedies market relies heavily on new product innovation. Greatly influenced by seasonal rhythms and the rising cost of healthcare, the market changes dramatically with changes in vaccines and in the prescription market.
This report will help you understand:
- The huge impact of prescription to over-the-counter switches in tablets, including Claritin and the impending migration of Zyrtec.
- The effect of the 2006 Stop Meth Act, which moved pseudoephedrine products behind the counter, inconveniencing customers and highlighting potential dangers of over-the-counter remedies.
- Activity from the seven leading remedy manufacturers, and the effect of the Johnson & Johnson/Pfizer merger on the supply chain and advertising/promotional strategies.
- The retail landscape, dominated by the drug channel, and the attempts of food and mass channels to adopt similar pharmaceutical services.
- Close inspection of consumer behavior regarding remedies and the conditions they treat, yielding ideas about how manufacturers can increase usage and penetration.
Moreover, this report features in-depth analysis of the future of the market, including potential of and competition from alternative remedies; the impact of voluntary withdrawal of infants' remedies; and the threat of FDA findings which may limit or stop sales of children' s remedies.
Not covered in this report are lozenges, medicated sweets, and products for the relief of coughs and sore throats.
Table of Contents
- Scope and ThemesWhat you need to know
- Definition
- Consumer research methodology
- Abbreviations and terms
- Abbreviations
- Terms
- Executive Summary
- Sales driven by incidence, population factors
- A healthy market boosted by Rx switches and new product launches
- Tablets lead market as liquids slip and nasal products gain ground
- Mergers consolidate supply structure
- Ad & promo
- Professional staff drive sales to drug channel--even for common cold and allergy remedies
- The consumer
- Incidence of ailments and usage of remedies
- Attitudes towards CF&A remedies
- The ethnic consumer
- What the future holds
- Market Drivers
- Incidence of cold, flu, and allergies
- Key points
- Details
- Figure 1: Severity of flu (only), October 2006
- Figure 2: Severity of nasal allergies/hay fever (only), October 2006
- Seasonal severity
- Figure 3: Influenza seasonal severity, in the U.S., 2000-06
- Higher contraction risk among children, women, elderly
- Figure 4: Population by age, 2002-12
- Figure 5: Population of OTC flu remedy users, based on those confirmed to have the flu, by gender, 2002-12
- Rx switches boost sales
- Uninsured turn to self-care, diagnosis
- Shift of pseudoephedrine to behind the counter
- Alternative remedies cut into OTC sales
- Vaccines and Rx remedies compete with OTC
- Figure 6: Preference for OTC vs. Rx cold, flu, and allergy remedies, October 2006
- Market Size and Trends
- Market size
- Figure 7: Total U.S. retail sales of cold, flu, and allergy remedies, at current and constant prices, 2002-07
- Wal-Mart estimate
- Market trends
- Multi-symptom relief
- Flavor
- Natural/organic ingredients
- Market Segmentation
- Cold, flu, and allergy remedy segments
- Figure 8: FDM sales of cold, flu, and allergy remedies, segmented by delivery form, 2005 and 2007
- Tablets
- Figure 9: Sales of cold, flu, and allergy remedy tablets, at current and constant prices, 2002-07
- Liquids
- Figure 10: Sales of cold, flu, and allergy remedy liquids, at current and constant prices, 2002-07
- Nasal products
- Figure 11: Sales of cold, flu, and allergy remedy nasal products, at current and constant prices, 2002-07
- Supply Structure
- Introduction
- Companies and brands
- Figure 12: Manufacturer FDM sales of cold, flu, and allergy remedies in the U.S., 2005 and 2007
- Tablets
- Figure 13: Manufacturer brand sales of cold, flu, and allergy remedy tablets, in the U.S., 2005 and 2007
- Liquids
- Figure 14: Manufacturer brand sales of cold, flu, and allergy remedy liquids, in the U.S., 2005 and 2007
- Nasal products
- Figure 15: Manufacturer brand sales of cold, flu, and allergy remedy nasal products, in the U.S., 2005 and 2007
- Advertising and Promotion
- Introduction
- Figure 16: Promotional expenditures of the top CF&A manufacturers*, 2005-06
- Television marketing campaigns
- Schering-Plough
- Figure 17: Corocidin TV spot--high blood pressure-safe
- Pfizer, Inc.
- Figure 18: PediaCare liquid TV spot--pediatrician-endorsed
- Figure 19: Sudacare Shower Soother and Sudacare Vapor Plug TV spot--non-medicated
- Figure 20: Sudacare Shower Soother TV spot--non-medicated
- Procter & Gamble
- Figure 21: Vicks NyQuil and Vicks DayQuil TV spot--fast relief
- Figure 22: Vicks NyQuil TV spot--tried and true
- McNeil
- Figure 23: Children' s Motrin liquid TV spot--pediatrician-endorsed
- Figure 24: Tylenol Cold Multi-Symptom TV spot--multi-symptom; comparative advertising
- Figure 25: Children' s Tylenol Plus Cold TV spot--multi-symptom; doctor-recommended
- Adams Respiratory Therapeutics
- Figure 26: Mucinex DM TV spot--memorable character
- Wyeth Labs, Inc.
- Figure 27: Advil TV spot--multi-symptom relief
- Figure 28: Robitussin TV spot--wide product range
- Novartis
- Figure 29: TheraFlu Warming relief TV spot--restorative
- Figure 30: Triaminic Nighttime Cold & Cough TV spot--child-friendly advertising
- Other companies
- Figure 31: Zicam TV spot--consumer testimonial
- Figure 32: Zicam Cough Max TV spot--convenience
- Figure 33: Alka-Seltzer Plus liquid TV spot--multi-symptom relief
- Figure 34: Aleve cold/sinus TV spot--"real people;" circumvents pseudoephedrine restrictions
- Retail Distribution
- Introduction
- Figure 35: U.S. FDM and convenience store retail sales of cold, flu, and allergy remedies, by channel, 2005 and 2007
- Drug stores
- Figure 36: U.S. drug store sales of cold, flu, and allergy remedies, at current and constant prices, 2002-07
- Supermarkets
- Figure 37: U.S. supermarket sales of cold, flu, and allergy remedies, at current and constant prices, 2002-07
- Mass merchandisers
- Figure 38: U.S. mass merchandiser sales of cold, flu, and allergy remedies, at current and constant prices, 2002-07
- Convenience stores
- Figure 39: U.S. convenience store sales of cold, flu, and allergy remedies, at current and constant prices, 2002-07
- The Consumer: Use of Cold, Flu, and Allergy Remedies
- Summary
- Incidence of ailments, usage of remedies
- Incidence of flu and allergies
- Figure 40: Incidence of flu and nasal allergies/hay fever, by age, January-October 2006
- Severity of flu and nasal allergies/hay fever
- Figure 41: Severity of flu and nasal allergies/hay fever, by age, January-October 2006
- Use of cold, flu, and sinus remedies
- Figure 42: Use of cold, flu, and allergy remedies, by age, January-October 2006
- Preferred brands of cold, flu, and allergy remedies
- Figure 43: Preferred brands of cold, flu, and allergy remedies, by age, January-October 2006
- Frequency of usage of cold, flu, and allergy remedies
- Figure 44: Frequency of usage of cold, flu, and allergy remedies, by age, January-October 2006
- OTC vs. Rx cold, flu, and allergy remedies
- Figure 45: Preference for OTC vs. Rx cold, flu, and allergy remedies, by age, January-October 2006
- Ailments treated with cold, flu, and allergy remedies
- Figure 46: Ailments treated with cold, flu, and allergy remedies, by age, January-October 2006
- Household usage of children' s cold, flu, and allergy remedies
- Figure 47: Household usage of children' s cold, flu, and allergy remedies, January-October 2006
- Types and brands of children' s remedies preferred among households
- Figure 48: Household preference for types and brands of children' s cold, flu, and allergy remedies, January-October 2006
- Teen use of cold, flu, and allergy remedies
- Figure 49: Teen use of cold, flu, and allergy remedies, by gender and age, January-October 2006
- The Consumer: Attitudes towards Cold, Flu, and Allergy Remedies and Their Side Effects
- Summary
- Attitudes towards cold, flu, and allergy remedies
- Figure 50: Attitudes towards cold, flu, and allergy remedies, by gender, August 2007
- Figure 51: Attitudes towards cold, flu, and allergy remedies, by age, August 2007
- Figure 52: Attitudes towards cold, flu, and allergy remedies, by number of children in household, August 2007
- Side effects from cold, flu, allergy remedies
- Figure 53: cold, flu, and allergy remedy side effects experienced in the past 12 months, by age, August 2007
- The Consumer: Ethnic Use of Cold, Flu, and Allergy Remedies
- Summary
- Incidence of ailments, usage of remedies among ethnicities
- Incidence of flu and allergies among ethnicities
- Figure 54: Incidence of flu and nasal allergies/hay fever, by race/ethnicity, January-October 2006
- Severity of flu and nasal allergies/hay fever among ethnicities
- Figure 55: Severity of flu and nasal allergies/hay fever, by race/ethnicity, January-October 2006
- Preferred formulations of cold, flu, and allergy remedies among ethnicities
- Figure 56: Preference for 4-6-hour or 12-hour cold, flu, and allergy remedies, by race/ethnicity, January-October 2006
- Preferred brands of cold, flu, and allergy remedies among ethnicities
- Figure 57: Preferred brands of cold, flu, and allergy remedies, by race/ethnicity, January-October 2006
- Frequency of usage of cold, flu, and allergy remedies among ethnicities
- Figure 58: Frequency of usage of cold, flu, and allergy remedies, by race/ethnicity, January-October 2006
- OTC vs. Rx cold, flu, and allergy remedies preferences among ethnicities
- Figure 59: Preference for OTC vs. Rx cold, flu, and allergy remedies, by race/ethnicity, January-October 2006
- Ailments ethnicities treat with cold, flu, and allergy remedies
- Figure 60: Ailments treated with cold, flu, and allergy remedies, by race/ethnicity, January-October 2006
- Attitudes towards cold, flu, and allergy remedies among ethnicities
- Figure 61: Attitudes towards cold, flu, and allergy remedies, by race/ethnicity, August 2007
- Side effects from cold, flu, allergy remedies experienced among ethnicities
- Figure 62: cold, flu, and allergy remedy side effects experienced in the past 12 months, by race/ethnicity, August 2007
- Future and Forecast
- Future trends
- OTC switch of Zyrtec promises market boost
- FDA advisory panel advises against children' s cough and cold remedies; manufacturers pull infants' remedies
- Market forecast
- Cold, flu, and allergy remedies
- Figure 63: Forecast of total U.S. retail sales of cold, flu, and allergy remedies, at current and constant prices, 2007-12
- Cold, flu, and allergy remedy tablets
- Figure 64: Forecast of U.S. FDM sales of cold, flu, and allergy remedy tablets, at current and constant prices, 2007-12
- Cold, flu, and allergy remedy liquids
- Figure 65: Forecast of U.S. FDM sales of cold, flu, and allergy remedy liquids, at current and constant prices, 2007-12
- Cold, flu, and allergy remedy nasal products
- Figure 66: Forecast of U.S. FDM sales of cold, flu, and allergy remedy nasal products, at current and constant prices, 2007-12
- Forecast factors
- Appendix: Trade Associations
